4010 POSTER Satraplatin increases progression-free survival (PFS) and delays pain progression in hormone refractory prostate cancer (HRPC): Results of SPARC, an international phase III trial with 950 patients

✍ Scribed by C. Sternberg; O. Sartor; D. Petrylak; J.A. Witjes; I. Bodrogi; P. Harper; J.P. Droz; N. James

• Book ID: 118625920
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 67 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)71078-9